305 related articles for article (PubMed ID: 27103022)
1. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE
J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
[TBL] [Abstract][Full Text] [Related]
3. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Evaluation of
Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
[No Abstract] [Full Text] [Related]
6. Pharmacokinetic Evaluation of the Tau PET Radiotracer
Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
[No Abstract] [Full Text] [Related]
7. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging Evaluation of Four σ
Baum E; Cai Z; Bois F; Holden D; Lin SF; Lara-Jaime T; Kapinos M; Chen Y; Deuther-Conrad W; Fischer S; Dukic-Stefanovic S; Bunse P; Wünsch B; Brust P; Jia H; Huang Y
J Nucl Med; 2017 Jun; 58(6):982-988. PubMed ID: 28232607
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [
Arakawa R; Takano A; Stenkrona P; Stepanov V; Nag S; Jahan M; Grybäck P; Bolin M; Chen L; Zhang L; He P; Villalobos A; McCarthy TJ; Halldin C; Varrone A
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2429-2439. PubMed ID: 32140803
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
[TBL] [Abstract][Full Text] [Related]
11. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
[TBL] [Abstract][Full Text] [Related]
12. Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand.
Zhang L; Villalobos A; Beck EM; Bocan T; Chappie TA; Chen L; Grimwood S; Heck SD; Helal CJ; Hou X; Humphrey JM; Lu J; Skaddan MB; McCarthy TJ; Verhoest PR; Wager TT; Zasadny K
J Med Chem; 2013 Jun; 56(11):4568-79. PubMed ID: 23651455
[TBL] [Abstract][Full Text] [Related]
13. Assessment of test-retest reproducibility of [
Li S; Naganawa M; Pracitto R; Najafzadeh S; Holden D; Henry S; Matuskey D; Emery PR; Cai Z; Ropchan J; Nabulsi N; Carson RE; Huang Y
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1327-1338. PubMed ID: 33416954
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
Kim JS; Ichise M; Sangare J; Innis RB
J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
[TBL] [Abstract][Full Text] [Related]
15. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
[TBL] [Abstract][Full Text] [Related]
16. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP
J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529
[TBL] [Abstract][Full Text] [Related]
17. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
Wong DF; Kuwabara H; Kim J; Brasic JR; Chamroonrat W; Gao Y; Valentine H; Willis W; Mathur A; McCaul ME; Wand G; Gean EG; Dannals RF; Horti AG
J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676
[TBL] [Abstract][Full Text] [Related]
18. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.
Fan Z; Calsolaro V; Atkinson RA; Femminella GD; Waldman A; Buckley C; Trigg W; Brooks DJ; Hinz R; Edison P
J Nucl Med; 2016 Nov; 57(11):1753-1759. PubMed ID: 27261523
[TBL] [Abstract][Full Text] [Related]
19. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
[TBL] [Abstract][Full Text] [Related]
20. First-in-Human Assessment of
Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
